nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—ERBB2—brain cancer	0.439	0.679	CbGaD
Lapatinib—EGFR—brain cancer	0.208	0.321	CbGaD
Lapatinib—CYP3A4—Temozolomide—brain cancer	0.0267	0.291	CbGbCtD
Lapatinib—CYP3A4—Lomustine—brain cancer	0.0227	0.248	CbGbCtD
Lapatinib—CYP3A5—Etoposide—brain cancer	0.014	0.154	CbGbCtD
Lapatinib—CYP2C8—Etoposide—brain cancer	0.0135	0.148	CbGbCtD
Lapatinib—ABCB1—Etoposide—brain cancer	0.00914	0.0999	CbGbCtD
Lapatinib—Metastatic disease—Hydroxyurea—brain cancer	0.00738	0.0762	CcSEcCtD
Lapatinib—Metastatic neoplasm—Procarbazine—brain cancer	0.00573	0.0592	CcSEcCtD
Lapatinib—CYP3A4—Etoposide—brain cancer	0.00548	0.0599	CbGbCtD
Lapatinib—Cardiotoxicity—Procarbazine—brain cancer	0.00466	0.0482	CcSEcCtD
Lapatinib—Metastatic neoplasm—Hydroxyurea—brain cancer	0.00444	0.0458	CcSEcCtD
Lapatinib—Metastatic neoplasm—Temozolomide—brain cancer	0.00347	0.0358	CcSEcCtD
Lapatinib—Cardiotoxicity—Etoposide—brain cancer	0.00226	0.0233	CcSEcCtD
Lapatinib—Hepatotoxicity—Lomustine—brain cancer	0.00224	0.0232	CcSEcCtD
Lapatinib—PIK3C2B—telencephalon—brain cancer	0.00177	0.0346	CbGeAlD
Lapatinib—PIK3C2B—Podofilox—Etoposide—brain cancer	0.00161	0.548	CbGdCrCtD
Lapatinib—ERBB4—brainstem—brain cancer	0.00155	0.0303	CbGeAlD
Lapatinib—TAP1—pituitary gland—brain cancer	0.00154	0.03	CbGeAlD
Lapatinib—Mucosal inflammation—Hydroxyurea—brain cancer	0.00154	0.0159	CcSEcCtD
Lapatinib—TAP1—medulla oblongata—brain cancer	0.00148	0.0289	CbGeAlD
Lapatinib—PIK3C2B—pituitary gland—brain cancer	0.00144	0.0281	CbGeAlD
Lapatinib—PIK3C2B—medulla oblongata—brain cancer	0.00139	0.0272	CbGeAlD
Lapatinib—ERBB4—telencephalon—brain cancer	0.00138	0.0269	CbGeAlD
Lapatinib—TAP1—midbrain—brain cancer	0.00136	0.0264	CbGeAlD
Lapatinib—ERBB2—Podofilox—Etoposide—brain cancer	0.00133	0.451	CbGdCrCtD
Lapatinib—TAP1—spinal cord—brain cancer	0.00132	0.0258	CbGeAlD
Lapatinib—Gefitinib—EGFR—brain cancer	0.00131	0.523	CrCbGaD
Lapatinib—PI4KB—telencephalon—brain cancer	0.00129	0.0252	CbGeAlD
Lapatinib—Neoplasm malignant—Procarbazine—brain cancer	0.00129	0.0133	CcSEcCtD
Lapatinib—PIK3C2B—midbrain—brain cancer	0.00127	0.0248	CbGeAlD
Lapatinib—PIK3C2B—spinal cord—brain cancer	0.00124	0.0242	CbGeAlD
Lapatinib—Gefitinib—CYP2C9—brain cancer	0.00119	0.477	CrCbGaD
Lapatinib—EGFR—telencephalon—brain cancer	0.00117	0.0228	CbGeAlD
Lapatinib—ERBB2—gonad—brain cancer	0.00115	0.0224	CbGeAlD
Lapatinib—ERBB4—pituitary gland—brain cancer	0.00112	0.0219	CbGeAlD
Lapatinib—PIK3C2B—endocrine gland—brain cancer	0.00112	0.0218	CbGeAlD
Lapatinib—PIK3C2B—head—brain cancer	0.0011	0.0215	CbGeAlD
Lapatinib—Hepatotoxicity—Hydroxyurea—brain cancer	0.0011	0.0114	CcSEcCtD
Lapatinib—ERBB4—medulla oblongata—brain cancer	0.00108	0.0211	CbGeAlD
Lapatinib—PI4KB—gonad—brain cancer	0.00108	0.021	CbGeAlD
Lapatinib—PI4KB—pituitary gland—brain cancer	0.00105	0.0205	CbGeAlD
Lapatinib—TAP1—cerebellum—brain cancer	0.00105	0.0204	CbGeAlD
Lapatinib—PI4KB—medulla oblongata—brain cancer	0.00102	0.0198	CbGeAlD
Lapatinib—PIK3C2B—central nervous system—brain cancer	0.00101	0.0196	CbGeAlD
Lapatinib—ERBB4—midbrain—brain cancer	0.000991	0.0193	CbGeAlD
Lapatinib—PIK3C2B—cerebellum—brain cancer	0.000986	0.0192	CbGeAlD
Lapatinib—Interstitial lung disease—Carmustine—brain cancer	0.000971	0.01	CcSEcCtD
Lapatinib—ERBB4—spinal cord—brain cancer	0.000967	0.0188	CbGeAlD
Lapatinib—Mucosal inflammation—Etoposide—brain cancer	0.00096	0.00992	CcSEcCtD
Lapatinib—Stomatitis—Lomustine—brain cancer	0.000944	0.00975	CcSEcCtD
Lapatinib—Interstitial lung disease—Temozolomide—brain cancer	0.000939	0.0097	CcSEcCtD
Lapatinib—PI4KB—midbrain—brain cancer	0.000928	0.0181	CbGeAlD
Lapatinib—PI4KB—spinal cord—brain cancer	0.000905	0.0176	CbGeAlD
Lapatinib—Hepatotoxicity—Carmustine—brain cancer	0.00089	0.0092	CcSEcCtD
Lapatinib—ERBB2—endocrine gland—brain cancer	0.00087	0.017	CbGeAlD
Lapatinib—ERBB4—endocrine gland—brain cancer	0.00087	0.017	CbGeAlD
Lapatinib—Hepatotoxicity—Temozolomide—brain cancer	0.00086	0.00889	CcSEcCtD
Lapatinib—ERBB2—head—brain cancer	0.000859	0.0167	CbGeAlD
Lapatinib—ERBB4—head—brain cancer	0.000859	0.0167	CbGeAlD
Lapatinib—TAP1—brain—brain cancer	0.000853	0.0166	CbGeAlD
Lapatinib—Nail disorder—Etoposide—brain cancer	0.00082	0.00847	CcSEcCtD
Lapatinib—PI4KB—endocrine gland—brain cancer	0.000815	0.0159	CbGeAlD
Lapatinib—PI4KB—head—brain cancer	0.000805	0.0157	CbGeAlD
Lapatinib—PIK3C2B—brain—brain cancer	0.000801	0.0156	CbGeAlD
Lapatinib—ERBB2—central nervous system—brain cancer	0.000784	0.0153	CbGeAlD
Lapatinib—ERBB4—central nervous system—brain cancer	0.000784	0.0153	CbGeAlD
Lapatinib—Alopecia—Lomustine—brain cancer	0.000768	0.00794	CcSEcCtD
Lapatinib—ERBB2—cerebellum—brain cancer	0.000767	0.0149	CbGeAlD
Lapatinib—ERBB4—cerebellum—brain cancer	0.000767	0.0149	CbGeAlD
Lapatinib—Interstitial lung disease—Etoposide—brain cancer	0.000751	0.00776	CcSEcCtD
Lapatinib—PI4KB—central nervous system—brain cancer	0.000735	0.0143	CbGeAlD
Lapatinib—Hyperbilirubinaemia—Temozolomide—brain cancer	0.000731	0.00755	CcSEcCtD
Lapatinib—PI4KB—cerebellum—brain cancer	0.000718	0.014	CbGeAlD
Lapatinib—Infection—Carboplatin—brain cancer	0.000701	0.00725	CcSEcCtD
Lapatinib—Hepatotoxicity—Etoposide—brain cancer	0.000688	0.00711	CcSEcCtD
Lapatinib—Leukopenia—Lomustine—brain cancer	0.000677	0.007	CcSEcCtD
Lapatinib—Renal failure acute—Hydroxyurea—brain cancer	0.000669	0.00691	CcSEcCtD
Lapatinib—EGFR—cerebellum—brain cancer	0.00065	0.0127	CbGeAlD
Lapatinib—ERBB2—brain—brain cancer	0.000623	0.0121	CbGeAlD
Lapatinib—ERBB4—brain—brain cancer	0.000623	0.0121	CbGeAlD
Lapatinib—Pneumonia—Procarbazine—brain cancer	0.000618	0.00639	CcSEcCtD
Lapatinib—Infection—Lomustine—brain cancer	0.000613	0.00634	CcSEcCtD
Lapatinib—Neuropathy peripheral—Procarbazine—brain cancer	0.000602	0.00623	CcSEcCtD
Lapatinib—Stomatitis—Procarbazine—brain cancer	0.000599	0.00619	CcSEcCtD
Lapatinib—Anorexia—Lomustine—brain cancer	0.000589	0.00608	CcSEcCtD
Lapatinib—PI4KB—brain—brain cancer	0.000583	0.0114	CbGeAlD
Lapatinib—Epistaxis—Procarbazine—brain cancer	0.00058	0.00599	CcSEcCtD
Lapatinib—Decreased appetite—Lomustine—brain cancer	0.000537	0.00555	CcSEcCtD
Lapatinib—EGFR—brain—brain cancer	0.000528	0.0103	CbGeAlD
Lapatinib—Hot flush—Temozolomide—brain cancer	0.000515	0.00533	CcSEcCtD
Lapatinib—Menopausal symptoms—Temozolomide—brain cancer	0.000511	0.00528	CcSEcCtD
Lapatinib—Neutropenia—Hydroxyurea—brain cancer	0.000499	0.00515	CcSEcCtD
Lapatinib—Alopecia—Procarbazine—brain cancer	0.000488	0.00504	CcSEcCtD
Lapatinib—Infestation NOS—Hydroxyurea—brain cancer	0.000476	0.00492	CcSEcCtD
Lapatinib—Infestation—Hydroxyurea—brain cancer	0.000476	0.00492	CcSEcCtD
Lapatinib—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000466	0.00482	CcSEcCtD
Lapatinib—Stomatitis—Hydroxyurea—brain cancer	0.000464	0.00479	CcSEcCtD
Lapatinib—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00045	0.00465	CcSEcCtD
Lapatinib—Dehydration—Temozolomide—brain cancer	0.000448	0.00463	CcSEcCtD
Lapatinib—Anaemia—Procarbazine—brain cancer	0.000444	0.00459	CcSEcCtD
Lapatinib—Dry skin—Temozolomide—brain cancer	0.000442	0.00457	CcSEcCtD
Lapatinib—Leukopenia—Procarbazine—brain cancer	0.00043	0.00444	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Temozolomide—brain cancer	0.000425	0.00439	CcSEcCtD
Lapatinib—Cough—Procarbazine—brain cancer	0.000419	0.00433	CcSEcCtD
Lapatinib—Arthralgia—Procarbazine—brain cancer	0.000409	0.00423	CcSEcCtD
Lapatinib—Myalgia—Procarbazine—brain cancer	0.000409	0.00423	CcSEcCtD
Lapatinib—Neutropenia—Carmustine—brain cancer	0.000403	0.00417	CcSEcCtD
Lapatinib—Cardiac failure—Etoposide—brain cancer	0.000395	0.00409	CcSEcCtD
Lapatinib—Vomiting—Lomustine—brain cancer	0.000393	0.00406	CcSEcCtD
Lapatinib—Neutropenia—Temozolomide—brain cancer	0.00039	0.00403	CcSEcCtD
Lapatinib—Infection—Procarbazine—brain cancer	0.000389	0.00402	CcSEcCtD
Lapatinib—Angiopathy—Hydroxyurea—brain cancer	0.000387	0.004	CcSEcCtD
Lapatinib—Pneumonia—Carmustine—brain cancer	0.000387	0.004	CcSEcCtD
Lapatinib—Alopecia—Hydroxyurea—brain cancer	0.000377	0.0039	CcSEcCtD
Lapatinib—Neuropathy peripheral—Carmustine—brain cancer	0.000377	0.0039	CcSEcCtD
Lapatinib—Stomatitis—Carmustine—brain cancer	0.000375	0.00387	CcSEcCtD
Lapatinib—Pneumonia—Temozolomide—brain cancer	0.000374	0.00386	CcSEcCtD
Lapatinib—Anorexia—Procarbazine—brain cancer	0.000374	0.00386	CcSEcCtD
Lapatinib—Infestation—Temozolomide—brain cancer	0.000372	0.00384	CcSEcCtD
Lapatinib—Infestation NOS—Temozolomide—brain cancer	0.000372	0.00384	CcSEcCtD
Lapatinib—ABCB1—blood vessel—brain cancer	0.000371	0.00722	CbGeAlD
Lapatinib—Nausea—Lomustine—brain cancer	0.000367	0.00379	CcSEcCtD
Lapatinib—Neuropathy peripheral—Temozolomide—brain cancer	0.000364	0.00376	CcSEcCtD
Lapatinib—Stomatitis—Temozolomide—brain cancer	0.000362	0.00374	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000357	0.00369	CcSEcCtD
Lapatinib—Insomnia—Procarbazine—brain cancer	0.000355	0.00366	CcSEcCtD
Lapatinib—Hepatobiliary disease—Temozolomide—brain cancer	0.000351	0.00363	CcSEcCtD
Lapatinib—Anaemia—Hydroxyurea—brain cancer	0.000344	0.00355	CcSEcCtD
Lapatinib—Decreased appetite—Procarbazine—brain cancer	0.000341	0.00352	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Etoposide—brain cancer	0.00034	0.00352	CcSEcCtD
Lapatinib—Connective tissue disorder—Carmustine—brain cancer	0.000339	0.00351	CcSEcCtD
Lapatinib—Fatigue—Procarbazine—brain cancer	0.000338	0.00349	CcSEcCtD
Lapatinib—Constipation—Procarbazine—brain cancer	0.000335	0.00346	CcSEcCtD
Lapatinib—Leukopenia—Hydroxyurea—brain cancer	0.000333	0.00344	CcSEcCtD
Lapatinib—Connective tissue disorder—Temozolomide—brain cancer	0.000328	0.00339	CcSEcCtD
Lapatinib—Gastrointestinal pain—Procarbazine—brain cancer	0.000321	0.00331	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000314	0.00325	CcSEcCtD
Lapatinib—Neutropenia—Etoposide—brain cancer	0.000312	0.00322	CcSEcCtD
Lapatinib—Abdominal pain—Procarbazine—brain cancer	0.00031	0.0032	CcSEcCtD
Lapatinib—Cardiac disorder—Temozolomide—brain cancer	0.00031	0.0032	CcSEcCtD
Lapatinib—CYP2C8—pituitary gland—brain cancer	0.000305	0.00595	CbGeAlD
Lapatinib—Alopecia—Carmustine—brain cancer	0.000305	0.00315	CcSEcCtD
Lapatinib—Angiopathy—Temozolomide—brain cancer	0.000303	0.00313	CcSEcCtD
Lapatinib—Mental disorder—Carmustine—brain cancer	0.000302	0.00313	CcSEcCtD
Lapatinib—Infection—Hydroxyurea—brain cancer	0.000301	0.00311	CcSEcCtD
Lapatinib—Immune system disorder—Temozolomide—brain cancer	0.000301	0.00311	CcSEcCtD
Lapatinib—Mediastinal disorder—Temozolomide—brain cancer	0.000301	0.00311	CcSEcCtD
Lapatinib—Malnutrition—Carmustine—brain cancer	0.000301	0.00311	CcSEcCtD
Lapatinib—Pneumonia—Etoposide—brain cancer	0.000299	0.00309	CcSEcCtD
Lapatinib—Nervous system disorder—Hydroxyurea—brain cancer	0.000298	0.00307	CcSEcCtD
Lapatinib—Infestation—Etoposide—brain cancer	0.000297	0.00307	CcSEcCtD
Lapatinib—Infestation NOS—Etoposide—brain cancer	0.000297	0.00307	CcSEcCtD
Lapatinib—Alopecia—Temozolomide—brain cancer	0.000295	0.00305	CcSEcCtD
Lapatinib—Skin disorder—Hydroxyurea—brain cancer	0.000295	0.00305	CcSEcCtD
Lapatinib—Mental disorder—Temozolomide—brain cancer	0.000292	0.00302	CcSEcCtD
Lapatinib—Neuropathy peripheral—Etoposide—brain cancer	0.000291	0.00301	CcSEcCtD
Lapatinib—Back pain—Carmustine—brain cancer	0.000291	0.003	CcSEcCtD
Lapatinib—Malnutrition—Temozolomide—brain cancer	0.00029	0.003	CcSEcCtD
Lapatinib—Stomatitis—Etoposide—brain cancer	0.00029	0.003	CcSEcCtD
Lapatinib—Anorexia—Hydroxyurea—brain cancer	0.000289	0.00299	CcSEcCtD
Lapatinib—Hypersensitivity—Procarbazine—brain cancer	0.000289	0.00298	CcSEcCtD
Lapatinib—Asthenia—Procarbazine—brain cancer	0.000281	0.00291	CcSEcCtD
Lapatinib—Hepatobiliary disease—Etoposide—brain cancer	0.000281	0.00291	CcSEcCtD
Lapatinib—Back pain—Temozolomide—brain cancer	0.000281	0.0029	CcSEcCtD
Lapatinib—Anaemia—Carmustine—brain cancer	0.000278	0.00287	CcSEcCtD
Lapatinib—Pruritus—Procarbazine—brain cancer	0.000277	0.00287	CcSEcCtD
Lapatinib—CYP2C19—endocrine gland—brain cancer	0.000271	0.00528	CbGeAlD
Lapatinib—Dyspnoea—Hydroxyurea—brain cancer	0.00027	0.00279	CcSEcCtD
Lapatinib—Leukopenia—Carmustine—brain cancer	0.000269	0.00278	CcSEcCtD
Lapatinib—Anaemia—Temozolomide—brain cancer	0.000268	0.00277	CcSEcCtD
Lapatinib—Diarrhoea—Procarbazine—brain cancer	0.000268	0.00277	CcSEcCtD
Lapatinib—Dyspepsia—Hydroxyurea—brain cancer	0.000267	0.00276	CcSEcCtD
Lapatinib—Decreased appetite—Hydroxyurea—brain cancer	0.000264	0.00273	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000262	0.00271	CcSEcCtD
Lapatinib—Fatigue—Hydroxyurea—brain cancer	0.000262	0.0027	CcSEcCtD
Lapatinib—Leukopenia—Temozolomide—brain cancer	0.00026	0.00269	CcSEcCtD
Lapatinib—Constipation—Hydroxyurea—brain cancer	0.000259	0.00268	CcSEcCtD
Lapatinib—Palpitations—Temozolomide—brain cancer	0.000257	0.00265	CcSEcCtD
Lapatinib—Myalgia—Carmustine—brain cancer	0.000256	0.00264	CcSEcCtD
Lapatinib—Cough—Temozolomide—brain cancer	0.000253	0.00262	CcSEcCtD
Lapatinib—Vomiting—Procarbazine—brain cancer	0.000249	0.00258	CcSEcCtD
Lapatinib—Cardiac disorder—Etoposide—brain cancer	0.000248	0.00256	CcSEcCtD
Lapatinib—Arthralgia—Temozolomide—brain cancer	0.000247	0.00255	CcSEcCtD
Lapatinib—Myalgia—Temozolomide—brain cancer	0.000247	0.00255	CcSEcCtD
Lapatinib—Rash—Procarbazine—brain cancer	0.000247	0.00255	CcSEcCtD
Lapatinib—Dermatitis—Procarbazine—brain cancer	0.000247	0.00255	CcSEcCtD
Lapatinib—Headache—Procarbazine—brain cancer	0.000246	0.00254	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000246	0.00254	CcSEcCtD
Lapatinib—Infection—Carmustine—brain cancer	0.000244	0.00252	CcSEcCtD
Lapatinib—Angiopathy—Etoposide—brain cancer	0.000242	0.0025	CcSEcCtD
Lapatinib—Immune system disorder—Etoposide—brain cancer	0.000241	0.00249	CcSEcCtD
Lapatinib—Mediastinal disorder—Etoposide—brain cancer	0.000241	0.00249	CcSEcCtD
Lapatinib—Anaphylactic shock—Temozolomide—brain cancer	0.000237	0.00245	CcSEcCtD
Lapatinib—CYP2C8—endocrine gland—brain cancer	0.000236	0.00461	CbGeAlD
Lapatinib—Alopecia—Etoposide—brain cancer	0.000236	0.00244	CcSEcCtD
Lapatinib—Infection—Temozolomide—brain cancer	0.000235	0.00243	CcSEcCtD
Lapatinib—Anorexia—Carmustine—brain cancer	0.000234	0.00242	CcSEcCtD
Lapatinib—Nausea—Procarbazine—brain cancer	0.000233	0.00241	CcSEcCtD
Lapatinib—Nervous system disorder—Temozolomide—brain cancer	0.000232	0.0024	CcSEcCtD
Lapatinib—Skin disorder—Temozolomide—brain cancer	0.00023	0.00238	CcSEcCtD
Lapatinib—Anorexia—Temozolomide—brain cancer	0.000226	0.00233	CcSEcCtD
Lapatinib—Back pain—Etoposide—brain cancer	0.000225	0.00232	CcSEcCtD
Lapatinib—Hypersensitivity—Hydroxyurea—brain cancer	0.000224	0.00231	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Carmustine—brain cancer	0.000223	0.00231	CcSEcCtD
Lapatinib—Insomnia—Carmustine—brain cancer	0.000222	0.00229	CcSEcCtD
Lapatinib—Dyspnoea—Carmustine—brain cancer	0.000219	0.00226	CcSEcCtD
Lapatinib—Asthenia—Hydroxyurea—brain cancer	0.000218	0.00225	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000216	0.00223	CcSEcCtD
Lapatinib—Anaemia—Etoposide—brain cancer	0.000215	0.00222	CcSEcCtD
Lapatinib—Insomnia—Temozolomide—brain cancer	0.000214	0.00222	CcSEcCtD
Lapatinib—CYP3A5—endocrine gland—brain cancer	0.000213	0.00416	CbGeAlD
Lapatinib—Decreased appetite—Carmustine—brain cancer	0.000213	0.0022	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Carmustine—brain cancer	0.000212	0.00219	CcSEcCtD
Lapatinib—Dyspnoea—Temozolomide—brain cancer	0.000211	0.00218	CcSEcCtD
Lapatinib—Constipation—Carmustine—brain cancer	0.00021	0.00217	CcSEcCtD
Lapatinib—Dyspepsia—Temozolomide—brain cancer	0.000209	0.00216	CcSEcCtD
Lapatinib—Leukopenia—Etoposide—brain cancer	0.000208	0.00215	CcSEcCtD
Lapatinib—Diarrhoea—Hydroxyurea—brain cancer	0.000208	0.00214	CcSEcCtD
Lapatinib—Decreased appetite—Temozolomide—brain cancer	0.000206	0.00213	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Temozolomide—brain cancer	0.000205	0.00211	CcSEcCtD
Lapatinib—Fatigue—Temozolomide—brain cancer	0.000204	0.00211	CcSEcCtD
Lapatinib—Cough—Etoposide—brain cancer	0.000203	0.0021	CcSEcCtD
Lapatinib—Constipation—Temozolomide—brain cancer	0.000203	0.00209	CcSEcCtD
Lapatinib—Gastrointestinal pain—Carmustine—brain cancer	0.000201	0.00207	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000196	0.00203	CcSEcCtD
Lapatinib—Abdominal pain—Carmustine—brain cancer	0.000194	0.002	CcSEcCtD
Lapatinib—Gastrointestinal pain—Temozolomide—brain cancer	0.000194	0.002	CcSEcCtD
Lapatinib—Vomiting—Hydroxyurea—brain cancer	0.000193	0.00199	CcSEcCtD
Lapatinib—Rash—Hydroxyurea—brain cancer	0.000191	0.00198	CcSEcCtD
Lapatinib—Dermatitis—Hydroxyurea—brain cancer	0.000191	0.00197	CcSEcCtD
Lapatinib—Headache—Hydroxyurea—brain cancer	0.00019	0.00196	CcSEcCtD
Lapatinib—Anaphylactic shock—Etoposide—brain cancer	0.00019	0.00196	CcSEcCtD
Lapatinib—Infection—Etoposide—brain cancer	0.000188	0.00195	CcSEcCtD
Lapatinib—Abdominal pain—Temozolomide—brain cancer	0.000187	0.00194	CcSEcCtD
Lapatinib—Skin disorder—Etoposide—brain cancer	0.000184	0.0019	CcSEcCtD
Lapatinib—Anorexia—Etoposide—brain cancer	0.000181	0.00187	CcSEcCtD
Lapatinib—Hypersensitivity—Carmustine—brain cancer	0.000181	0.00187	CcSEcCtD
Lapatinib—Nausea—Hydroxyurea—brain cancer	0.00018	0.00186	CcSEcCtD
Lapatinib—ABCB1—telencephalon—brain cancer	0.00018	0.0035	CbGeAlD
Lapatinib—Asthenia—Carmustine—brain cancer	0.000176	0.00182	CcSEcCtD
Lapatinib—Hypersensitivity—Temozolomide—brain cancer	0.000175	0.0018	CcSEcCtD
Lapatinib—Asthenia—Temozolomide—brain cancer	0.00017	0.00176	CcSEcCtD
Lapatinib—CYP2C8—brain—brain cancer	0.000169	0.0033	CbGeAlD
Lapatinib—Dyspnoea—Etoposide—brain cancer	0.000169	0.00175	CcSEcCtD
Lapatinib—Diarrhoea—Carmustine—brain cancer	0.000168	0.00173	CcSEcCtD
Lapatinib—Pruritus—Temozolomide—brain cancer	0.000168	0.00173	CcSEcCtD
Lapatinib—Decreased appetite—Etoposide—brain cancer	0.000165	0.0017	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Etoposide—brain cancer	0.000164	0.00169	CcSEcCtD
Lapatinib—Fatigue—Etoposide—brain cancer	0.000164	0.00169	CcSEcCtD
Lapatinib—Constipation—Etoposide—brain cancer	0.000162	0.00168	CcSEcCtD
Lapatinib—Diarrhoea—Temozolomide—brain cancer	0.000162	0.00168	CcSEcCtD
Lapatinib—CYP3A4—endocrine gland—brain cancer	0.00016	0.00312	CbGeAlD
Lapatinib—Vomiting—Carmustine—brain cancer	0.000156	0.00161	CcSEcCtD
Lapatinib—Gastrointestinal pain—Etoposide—brain cancer	0.000155	0.0016	CcSEcCtD
Lapatinib—Rash—Carmustine—brain cancer	0.000155	0.0016	CcSEcCtD
Lapatinib—Dermatitis—Carmustine—brain cancer	0.000154	0.0016	CcSEcCtD
Lapatinib—Headache—Carmustine—brain cancer	0.000154	0.00159	CcSEcCtD
Lapatinib—Vomiting—Temozolomide—brain cancer	0.000151	0.00156	CcSEcCtD
Lapatinib—ABCB1—gonad—brain cancer	0.00015	0.00292	CbGeAlD
Lapatinib—Abdominal pain—Etoposide—brain cancer	0.00015	0.00155	CcSEcCtD
Lapatinib—Rash—Temozolomide—brain cancer	0.000149	0.00154	CcSEcCtD
Lapatinib—Dermatitis—Temozolomide—brain cancer	0.000149	0.00154	CcSEcCtD
Lapatinib—Headache—Temozolomide—brain cancer	0.000148	0.00153	CcSEcCtD
Lapatinib—ABCB1—pituitary gland—brain cancer	0.000146	0.00285	CbGeAlD
Lapatinib—Nausea—Carmustine—brain cancer	0.000146	0.00151	CcSEcCtD
Lapatinib—CYP3A4—central nervous system—brain cancer	0.000144	0.00281	CbGeAlD
Lapatinib—ABCB1—medulla oblongata—brain cancer	0.000141	0.00275	CbGeAlD
Lapatinib—Nausea—Temozolomide—brain cancer	0.000141	0.00145	CcSEcCtD
Lapatinib—Hypersensitivity—Etoposide—brain cancer	0.00014	0.00144	CcSEcCtD
Lapatinib—Asthenia—Etoposide—brain cancer	0.000136	0.00141	CcSEcCtD
Lapatinib—Pruritus—Etoposide—brain cancer	0.000134	0.00139	CcSEcCtD
Lapatinib—Diarrhoea—Etoposide—brain cancer	0.00013	0.00134	CcSEcCtD
Lapatinib—ABCB1—midbrain—brain cancer	0.000129	0.00251	CbGeAlD
Lapatinib—ABCB1—spinal cord—brain cancer	0.000126	0.00245	CbGeAlD
Lapatinib—Vomiting—Etoposide—brain cancer	0.000121	0.00125	CcSEcCtD
Lapatinib—Rash—Etoposide—brain cancer	0.00012	0.00124	CcSEcCtD
Lapatinib—Dermatitis—Etoposide—brain cancer	0.000119	0.00123	CcSEcCtD
Lapatinib—Headache—Etoposide—brain cancer	0.000119	0.00123	CcSEcCtD
Lapatinib—ABCB1—endocrine gland—brain cancer	0.000113	0.00221	CbGeAlD
Lapatinib—Nausea—Etoposide—brain cancer	0.000113	0.00116	CcSEcCtD
Lapatinib—ABCB1—head—brain cancer	0.000112	0.00218	CbGeAlD
Lapatinib—ABCB1—central nervous system—brain cancer	0.000102	0.00199	CbGeAlD
Lapatinib—ABCB1—cerebellum—brain cancer	9.99e-05	0.00195	CbGeAlD
Lapatinib—ABCB1—brain—brain cancer	8.11e-05	0.00158	CbGeAlD
Lapatinib—EGFR—B Cell Activation—ERBB2—brain cancer	3.01e-05	0.000277	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—RELA—brain cancer	2.98e-05	0.000274	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—STAT3—brain cancer	2.98e-05	0.000274	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	2.88e-05	0.000265	CbGpPWpGaD
Lapatinib—ERBB2—Axon guidance—EGFR—brain cancer	2.87e-05	0.000264	CbGpPWpGaD
Lapatinib—ERBB2—Disease—VAV1—brain cancer	2.85e-05	0.000262	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.85e-05	0.000262	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	2.84e-05	0.000262	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—IL2—brain cancer	2.84e-05	0.000261	CbGpPWpGaD
Lapatinib—TAP1—Immune System—EGFR—brain cancer	2.81e-05	0.000258	CbGpPWpGaD
Lapatinib—ERBB4—Disease—VAV1—brain cancer	2.81e-05	0.000258	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.79e-05	0.000257	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.78e-05	0.000256	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SHH—brain cancer	2.76e-05	0.000254	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.76e-05	0.000254	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SHH—brain cancer	2.72e-05	0.00025	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—CCND1—brain cancer	2.72e-05	0.00025	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	2.7e-05	0.000249	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—CTNNB1—brain cancer	2.69e-05	0.000247	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	2.68e-05	0.000246	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—STAT3—brain cancer	2.68e-05	0.000246	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TRPC6—brain cancer	2.66e-05	0.000245	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—STAT3—brain cancer	2.66e-05	0.000245	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—RELA—brain cancer	2.63e-05	0.000242	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.63e-05	0.000242	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TRPC6—brain cancer	2.62e-05	0.000241	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SMO—brain cancer	2.62e-05	0.000241	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PTCH1—brain cancer	2.62e-05	0.000241	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TP53—brain cancer	2.62e-05	0.000241	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—MYC—brain cancer	2.62e-05	0.000241	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PTCH2—brain cancer	2.59e-05	0.000239	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—RELA—brain cancer	2.59e-05	0.000238	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—CTNNB1—brain cancer	2.59e-05	0.000238	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PTCH1—brain cancer	2.58e-05	0.000237	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SMO—brain cancer	2.58e-05	0.000237	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—ERBB2—brain cancer	2.57e-05	0.000237	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.57e-05	0.000236	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—VAV1—brain cancer	2.56e-05	0.000236	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—PDGFRA—brain cancer	2.53e-05	0.000233	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—RELA—brain cancer	2.53e-05	0.000232	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HES5—brain cancer	2.51e-05	0.000231	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—HES1—brain cancer	2.5e-05	0.00023	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—PDGFRA—brain cancer	2.49e-05	0.000229	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—RELA—brain cancer	2.49e-05	0.000229	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—STAT3—brain cancer	2.48e-05	0.000228	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—ERBB2—brain cancer	2.47e-05	0.000227	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—VAV1—brain cancer	2.46e-05	0.000226	CbGpPWpGaD
Lapatinib—ERBB2—Disease—HES1—brain cancer	2.45e-05	0.000226	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.44e-05	0.000225	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—STRADA—brain cancer	2.44e-05	0.000224	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—STAT3—brain cancer	2.43e-05	0.000223	CbGpPWpGaD
Lapatinib—ERBB4—Disease—HES1—brain cancer	2.42e-05	0.000222	CbGpPWpGaD
Lapatinib—EGFR—Disease—IDH1—brain cancer	2.41e-05	0.000222	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.41e-05	0.000222	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—MYC—brain cancer	2.4e-05	0.000221	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—VEGFA—brain cancer	2.37e-05	0.000218	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	2.36e-05	0.000217	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.35e-05	0.000216	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PDGFRA—brain cancer	2.33e-05	0.000215	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PDGFRA—brain cancer	2.3e-05	0.000212	CbGpPWpGaD
Lapatinib—EGFR—Disease—HEY1—brain cancer	2.29e-05	0.00021	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CTNNB1—brain cancer	2.29e-05	0.00021	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—brain cancer	2.28e-05	0.00021	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—VEGFA—brain cancer	2.28e-05	0.00021	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—SHH—brain cancer	2.26e-05	0.000208	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—STAT3—brain cancer	2.26e-05	0.000208	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CTNNB1—brain cancer	2.25e-05	0.000207	CbGpPWpGaD
Lapatinib—EGFR—Disease—DLL1—brain cancer	2.24e-05	0.000206	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—RELA—brain cancer	2.23e-05	0.000205	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IRS2—brain cancer	2.22e-05	0.000204	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—ERBB2—brain cancer	2.22e-05	0.000204	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	2.2e-05	0.000202	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IRS2—brain cancer	2.19e-05	0.000201	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—TRPC6—brain cancer	2.18e-05	0.000201	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	2.17e-05	0.000199	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—brain cancer	2.15e-05	0.000198	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—SMO—brain cancer	2.14e-05	0.000197	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—PTCH1—brain cancer	2.14e-05	0.000197	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	2.11e-05	0.000194	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—PDGFRA—brain cancer	2.1e-05	0.000193	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NOTCH2—brain cancer	2.09e-05	0.000193	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NOTCH2—brain cancer	2.06e-05	0.00019	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—EGFR—brain cancer	2.05e-05	0.000189	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IRS2—brain cancer	2.05e-05	0.000189	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ABR—brain cancer	2.03e-05	0.000187	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IRS2—brain cancer	2.02e-05	0.000186	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—PDGFRA—brain cancer	2.02e-05	0.000185	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—ERBB2—brain cancer	2.01e-05	0.000184	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VAV1—brain cancer	2e-05	0.000184	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.99e-05	0.000183	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—brain cancer	1.97e-05	0.000181	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VAV1—brain cancer	1.97e-05	0.000181	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GLI2—brain cancer	1.97e-05	0.000181	CbGpPWpGaD
Lapatinib—EGFR—Immune System—SKP2—brain cancer	1.96e-05	0.00018	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—CDK4—brain cancer	1.96e-05	0.00018	CbGpPWpGaD
Lapatinib—EGFR—Disease—SHH—brain cancer	1.91e-05	0.000175	CbGpPWpGaD
Lapatinib—EGFR—Disease—ENO2—brain cancer	1.91e-05	0.000175	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CYP2C9—brain cancer	1.85e-05	0.00017	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GLI1—brain cancer	1.85e-05	0.00017	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IRS2—brain cancer	1.84e-05	0.000169	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—EGFR—brain cancer	1.81e-05	0.000167	CbGpPWpGaD
Lapatinib—ERBB2—Disease—APC—brain cancer	1.81e-05	0.000166	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—EGFR—brain cancer	1.78e-05	0.000164	CbGpPWpGaD
Lapatinib—ERBB4—Disease—APC—brain cancer	1.78e-05	0.000164	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.78e-05	0.000164	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—IRS2—brain cancer	1.77e-05	0.000163	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SUFU—brain cancer	1.75e-05	0.000161	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—EGFR—brain cancer	1.74e-05	0.00016	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—HES1—brain cancer	1.72e-05	0.000158	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—EGFR—brain cancer	1.71e-05	0.000158	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—HES1—brain cancer	1.69e-05	0.000156	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GFAP—brain cancer	1.69e-05	0.000155	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—STAT3—brain cancer	1.69e-05	0.000155	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.66e-05	0.000153	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PDGFRA—brain cancer	1.63e-05	0.00015	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—VAV1—brain cancer	1.63e-05	0.00015	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PDGFRA—brain cancer	1.61e-05	0.000148	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HEY1—brain cancer	1.6e-05	0.000147	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CYP2C9—brain cancer	1.6e-05	0.000147	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—SPP1—brain cancer	1.59e-05	0.000146	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—BSG—brain cancer	1.57e-05	0.000145	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—DLL1—brain cancer	1.57e-05	0.000145	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—SPP1—brain cancer	1.56e-05	0.000144	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.54e-05	0.000142	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—VEGFA—brain cancer	1.54e-05	0.000142	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—RELA—brain cancer	1.53e-05	0.000141	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—RELA—brain cancer	1.51e-05	0.000139	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—ERBB2—brain cancer	1.5e-05	0.000138	CbGpPWpGaD
Lapatinib—EGFR—Immune System—VAV1—brain cancer	1.49e-05	0.000137	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—RELA—brain cancer	1.44e-05	0.000132	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IRS2—brain cancer	1.44e-05	0.000132	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—ERBB2—brain cancer	1.43e-05	0.000132	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CYP2C9—brain cancer	1.43e-05	0.000131	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IRS2—brain cancer	1.41e-05	0.00013	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CYP2C9—brain cancer	1.4e-05	0.000128	CbGpPWpGaD
Lapatinib—ERBB4—Disease—ERBB2—brain cancer	1.38e-05	0.000127	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL2—brain cancer	1.38e-05	0.000127	CbGpPWpGaD
Lapatinib—EGFR—Disease—VAV1—brain cancer	1.38e-05	0.000127	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.36e-05	0.000126	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—BSG—brain cancer	1.36e-05	0.000125	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL2—brain cancer	1.36e-05	0.000125	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—IDH1—brain cancer	1.35e-05	0.000124	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.35e-05	0.000124	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SHH—brain cancer	1.34e-05	0.000123	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CTNNB1—brain cancer	1.33e-05	0.000123	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CTNNB1—brain cancer	1.31e-05	0.000121	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TRPC6—brain cancer	1.29e-05	0.000118	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—RELA—brain cancer	1.27e-05	0.000117	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—PIK3CG—brain cancer	1.27e-05	0.000117	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—APC—brain cancer	1.27e-05	0.000117	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PTCH1—brain cancer	1.27e-05	0.000116	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SMO—brain cancer	1.27e-05	0.000116	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—ERBB2—brain cancer	1.26e-05	0.000116	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—CTNNB1—brain cancer	1.25e-05	0.000115	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—PIK3CG—brain cancer	1.25e-05	0.000115	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—APC—brain cancer	1.25e-05	0.000115	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CTNNB1—brain cancer	1.23e-05	0.000113	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PDGFRA—brain cancer	1.22e-05	0.000112	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—RELA—brain cancer	1.22e-05	0.000112	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—BSG—brain cancer	1.22e-05	0.000112	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ERBB2—brain cancer	1.21e-05	0.000112	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CTNNB1—brain cancer	1.21e-05	0.000111	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.19e-05	0.000109	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—BSG—brain cancer	1.19e-05	0.000109	CbGpPWpGaD
Lapatinib—EGFR—Disease—HES1—brain cancer	1.19e-05	0.000109	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—IDH1—brain cancer	1.17e-05	0.000108	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—STAT3—brain cancer	1.16e-05	0.000107	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—STAT3—brain cancer	1.14e-05	0.000105	CbGpPWpGaD
Lapatinib—EGFR—Disease—PDGFRA—brain cancer	1.13e-05	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CTNNB1—brain cancer	1.11e-05	0.000102	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—VEGFA—brain cancer	1.1e-05	0.000101	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.09e-05	0.000101	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—STAT3—brain cancer	1.09e-05	0.0001	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IRS2—brain cancer	1.07e-05	9.87e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—STAT3—brain cancer	1.07e-05	9.86e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.07e-05	9.85e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ENO2—brain cancer	1.07e-05	9.83e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—STAT3—brain cancer	1.06e-05	9.71e-05	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—EGFR—brain cancer	1.06e-05	9.71e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—IDH1—brain cancer	1.05e-05	9.61e-05	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—EGFR—brain cancer	1.04e-05	9.56e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—PIK3CG—brain cancer	1.04e-05	9.54e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—IDH1—brain cancer	1.02e-05	9.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NOTCH2—brain cancer	1.01e-05	9.31e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MYC—brain cancer	9.96e-06	9.16e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IRS2—brain cancer	9.91e-06	9.11e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—RELA—brain cancer	9.91e-06	9.11e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MYC—brain cancer	9.81e-06	9.02e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—RELA—brain cancer	9.76e-06	8.97e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—EGFR—brain cancer	9.74e-06	8.96e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ERBB2—brain cancer	9.7e-06	8.92e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VAV1—brain cancer	9.65e-06	8.88e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—EGFR—brain cancer	9.6e-06	8.83e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.53e-06	8.77e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ENO2—brain cancer	9.26e-06	8.51e-05	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	8.99e-06	8.27e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL2—brain cancer	8.92e-06	8.2e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL2—brain cancer	8.79e-06	8.08e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—APC—brain cancer	8.75e-06	8.05e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CCND1—brain cancer	8.7e-06	8e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CTNNB1—brain cancer	8.61e-06	7.92e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CYP2C9—brain cancer	8.6e-06	7.91e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CCND1—brain cancer	8.57e-06	7.88e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.51e-06	7.83e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CTNNB1—brain cancer	8.48e-06	7.8e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—HES1—brain cancer	8.3e-06	7.63e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ENO2—brain cancer	8.26e-06	7.6e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ENO2—brain cancer	8.06e-06	7.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PDGFRA—brain cancer	7.9e-06	7.27e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—SPP1—brain cancer	7.67e-06	7.06e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—VEGFA—brain cancer	7.58e-06	6.97e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—STAT3—brain cancer	7.51e-06	6.9e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—VEGFA—brain cancer	7.47e-06	6.87e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—RELA—brain cancer	7.41e-06	6.81e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—STAT3—brain cancer	7.39e-06	6.8e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ERBB2—brain cancer	7.36e-06	6.77e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—BSG—brain cancer	7.31e-06	6.72e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2—brain cancer	7.3e-06	6.71e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MYC—brain cancer	6.98e-06	6.42e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IRS2—brain cancer	6.94e-06	6.38e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MYC—brain cancer	6.87e-06	6.32e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—EGFR—brain cancer	6.82e-06	6.27e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—ERBB2—brain cancer	6.8e-06	6.25e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—EGFR—brain cancer	6.72e-06	6.18e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2—brain cancer	6.67e-06	6.13e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CTNNB1—brain cancer	6.44e-06	5.92e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—IDH1—brain cancer	6.29e-06	5.78e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PIK3CG—brain cancer	6.13e-06	5.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—APC—brain cancer	6.13e-06	5.64e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CTNNB1—brain cancer	5.95e-06	5.47e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—brain cancer	5.73e-06	5.27e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—brain cancer	5.64e-06	5.19e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—STAT3—brain cancer	5.61e-06	5.16e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—STAT3—brain cancer	5.18e-06	4.77e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ENO2—brain cancer	4.97e-06	4.57e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PIK3CG—brain cancer	4.9e-06	4.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—MYC—brain cancer	4.82e-06	4.43e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RELA—brain cancer	4.79e-06	4.4e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ERBB2—brain cancer	4.76e-06	4.38e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2—brain cancer	4.31e-06	3.97e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PIK3CG—brain cancer	4.25e-06	3.91e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCND1—brain cancer	4.2e-06	3.87e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CTNNB1—brain cancer	4.16e-06	3.83e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PIK3CG—brain cancer	3.79e-06	3.49e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PIK3CG—brain cancer	3.7e-06	3.4e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—VEGFA—brain cancer	3.67e-06	3.37e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—STAT3—brain cancer	3.63e-06	3.34e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MYC—brain cancer	3.37e-06	3.1e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—brain cancer	2.77e-06	2.55e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PIK3CG—brain cancer	2.28e-06	2.1e-05	CbGpPWpGaD
